文献速递耳科与耳神经

美国成人听力损失管理临床试验的种族/民族与性别代表性:系统综述

Racial/Ethnic and Sex Representation in US-Based Clinical Trials of Hearing Loss Management in Adults: A Systematic Review.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2021-01-01

该系统综述检索PubMed、Embase和ClinicalTrials.gov,纳入1990年1月至2020年7月在美国进行的125项成人听力损失管理前瞻性研究。仅16项(12.8%)报告种族/民族,88项(70.4%)报告性别;报告种族/民族的研究中,少数种族/民族参与者中位数仅9人,报告性别的研究中女性平均占41%。结论认为这些试验未充分反映美国人口构成。

要点

  • 仅12.8%的听力损失管理临床试验报告种族/民族,70.4%报告性别。
  • 报告种族/民族的16项研究中,少数种族/民族参与者中位数仅9人。
  • 报告性别的88项研究中,女性参与者平均占41%,44项女性占比超45%。

核心结论

  • 研究听力损失管理的临床试验在种族/民族和性别代表性上未充分反映美国人口构成。

研究设计与样本

  • 系统综述,检索PubMed、Embase和ClinicalTrials.gov,检索获6196项研究。
  • 纳入125项在美国进行、以英文发表、评估成人听力损失管理的前瞻性研究。
  • 纳入干预包括助听器或辅助听力设备、人工耳蜗、听觉康复和治疗。
  • 仅纳入涉及双侧感音神经性听力损失的研究。

主要发现

  • 125项研究中仅16项(12.8%)报告种族/民族,88项(70.4%)报告性别。
  • 报告种族/民族的16项研究中,仅5项非白人参与者超过30%。
  • 报告性别的88项研究中,44项(35.2%)女性参与者超过45%。
  • 报告种族/民族的研究中,少数种族/民族参与者中位数为9人(范围1-77)。
  • 报告性别的分析中,女性参与者中位数为12人;报告性别的研究中女性平均占41%(范围1.55%-77.5%)。

关键数值与推荐

  • 报告种族/民族的16项研究中,少数种族/民族参与者平均占30%(范围1.96%-100%)。
  • 所观察试验的平均参与者数为80人(范围7-644)。
  • 种族/民族报告情况因资助来源和期刊类型而异,性别报告情况仅因期刊类型而异。

临床怎么用

  • 解读听力损失管理临床试验证据时,应注意其种族/民族和性别代表性不足可能影响结果外推。
  • 设计或评审相关临床试验时,应关注并报告种族/民族与性别构成,以促进公平和针对性干预。

局限性

  • 仅纳入英文发表、在美国进行、针对双侧感音神经性听力损失的前瞻性研究。
  • 种族/民族和性别报告率低,限制了对代表性的全面评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Although the National Institutes of Health (NIH) mandated the inclusion and reporting of women and racial or ethnic minority groups in NIH-funded research in 1993, little is known regarding the representation of women and racial or ethnic minority groups in trials that investigate hearing loss management. OBJECTIVE: To assess sex and racial/ethnic representation in US-based clinical trials of hearing loss management in an adult population. DATA SOURCES: Pertinent studies were identified using search strategies in PubMed, Embase, and ClinicalTrials.gov. STUDY SELECTION: Our search strategy yielded 6196 studies. We included prospective studies that were written in English, performed in the US, and evaluated hearing loss management in adults, including amplification devices, such as hearing aids or assistive listening devices, cochlear implants, aural rehabilitation, and therapeutics. Given its prevalence, only studies that addressed bilateral sensorineural hearing loss were included. DATA EXTRACTION AND SYNTHESIS: Data from 125 studies were extracted. The Preferred Reporting Items for Systematic Reviews and Meta-analyses diagram for systematic reviews was used for abstracting data. The guidelines were applied using independent extraction by multiple observers. RESULTS: Among 125 clinical studies performed from January 1990 to July 2020 regarding hearing loss management, only 16 (12.8%) reported race/ethnicity, and 88 (70.4%) reported sex. Of the 16 studies that reported race/ethnicity, only 5 included more than 30% non-White representation. Among the 88 articles that reported sex, 44 (35.2%) reported more than 45% female representation. While the mean number of participants included in the observed trials was 80 (range, 7-644), the median number of participants from racial or ethnic minority groups in studies that reported race/ethnicity was 9 (range, 1-77), and a median of 12 female participants were included in studies with a numerical breakdown by sex. A mean of 41% (range, 1.55%-77.5%) of participants were female among studies that reported sex, and a mean of 30% (range, 1.96%-100%) of participants were from racial or ethnic minority groups among the 16 studies that reported race/ethnicity. Reporting of race/ethnicity varied substantially by funding source and journal type, while reporting by sex differed only by journal type. CONCLUSIONS AND RELEVANCE: Studies investigating hearing loss management do not adequately reflect the US population. A closer examination of the inclusion of diverse adults in clinical research associated with hearing health may work to ameliorate disparities and contribute to the development of tailored interventions that address the needs of an increasingly diverse US population.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Pittman CA, Roura R, Price C, et al. Racial/Ethnic and Sex Representation in US-Based Clinical Trials of Hearing Loss Management in Adults: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 33885733. doi:10.1001/jamaoto.2021.0550

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。